New study of ultrasound enhancing agents in echocardiography reaffirms safety profile of LUMASON® (sulfur hexafluoride lipid-type A microspheres) for injectable suspension, for intravenous use or intravesical use
Advertisement
Data show only one non-serious adverse event reported with LUMASON ultrasound enhancing agent in 2,137 administrations